Furthermore, ectopic administration of cGAMP in vivo has been shown to elevate the infiltration of tumor-specific CD4+ T-cells, macrophages, dendritic cells, and CD8+ T-cells, leading to the increased production of type I IFN and ISGs. This evidence concerns the gene CD8A and neoplasm.